Company Data
XBiotech Inc.
Ticker
XBIT
Current Price
$3.17 6.73%
Market Cap
$96.6M
Price Target
Refer to Report
Volume
56.8K
52wk Range
$2.5 - $8.32
Overview
XBiotech Inc is an US based clinical-stage biopharmaceutical company which is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. It has developed therapeutic antibody Xilonix which is being evaluated as a monotherapy to treat advanced stages of colorectal cancer. Xilonix neutralizes a pro-inflammatory protein produced by leukocytes and other cells.